Article info

Download PDFPDF

Short report
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

Authors

  1. Correspondence to Dr Agnès Coste; agnes.coste{at}univ-tlse3.fr
View Full Text

Citation

Prat M, Le Naour A, Coulson K, et al
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

Publication history

  • Accepted May 2, 2020
  • First published June 4, 2020.
Online issue publication 
June 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.